Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RXRX Recursion Pharmaceuticals, Inc.

盘后交易 02-17 17:15:59 EST

3.46

-0.03

-0.86%

盘后3.39

-0.07-2.02%

17:15 EST

最高3.49	最低3.31	成交量1,701万
今开3.48	昨收3.49	日振幅5.16%
总市值17.99亿	流通市值14.36亿	总股本5.20亿
成交额5,777万	换手率4.10%	流通股本4.15亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RXRX","market":"US","secType":"STK","nameCN":"Recursion Pharmaceuticals, Inc.","latestPrice":3.46,"timestamp":1771362000000,"preClose":3.49,"halted":0,"volume":17007101,"hourTrading":{"tag":"盘后","latestPrice":3.39,"preClose":3.46,"latestTime":"17:15 EST","volume":163779,"amount":560635.7600844,"timestamp":1771366559602,"change":-0.07,"changeRate":-0.020231,"amplitude":0.046243},"delay":0,"changeRate":-0.00859598853868202,"floatShares":415000000,"shares":519837585,"eps":-1.783934,"marketStatus":"盘后交易","change":-0.03,"latestTime":"02-17 17:15:59 EST","open":3.48,"high":3.49,"low":3.31,"amount":57773402.7141665,"amplitude":0.051576,"askPrice":3.44,"askSize":50,"bidPrice":3.38,"bidSize":33,"shortable":3,"etf":0,"ttmEps":-1.783934,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1771376400000},"marketStatusCode":4,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":3.49,"preHourTrading":{"tag":"盘前","latestPrice":3.48,"preClose":3.49,"latestTime":"09:29 EST","volume":261704,"amount":912091.1471855999,"timestamp":1771338599999,"change":-0.01,"changeRate":-0.002865,"amplitude":0.011461},"postHourTrading":{"tag":"盘后","latestPrice":3.39,"preClose":3.46,"latestTime":"17:15 EST","volume":163779,"amount":560635.7600844,"timestamp":1771366559602,"change":-0.07,"changeRate":-0.020231,"amplitude":0.046243},"volumeRatio":1.005548,"optionData":{"bulkOrders":[{"symbol":"RXRX","call":true,"expireDate":1771563600000,"strike":"3.5","timestamp":1771339128135,"price":0.12,"volume":3000,"amount":36000,"type":"-"},{"symbol":"RXRX","call":true,"expireDate":1771563600000,"strike":"4.0","timestamp":1771338667417,"price":0.01,"volume":2499,"amount":2499,"type":"-"}]},"impliedVol":1.3442,"impliedVolPercentile":0.9801},"requestUrl":"/m/hq/s/RXRX/tweets","defaultTab":"tweets","newsList":[{"id":"1184411358","title":"英伟达持仓概念股拉升，NEBIUS涨超6%，APLD涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184411358","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184411358?lang=zh_cn&edition=full","pubTime":"2025-12-22 23:05","pubTimestamp":1766415910,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals涨超4%。","market":"us","thumbnail":"https://static.tigerbbs.com/7308276753c5ff6ceaac8e2cceebffd3","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/7308276753c5ff6ceaac8e2cceebffd3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9bf3257ea15a5c7e9e37f3b148f92d3a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBIS","APLD","RXRX","CRWV","WRD"],"gpt_icon":0},{"id":"2592922274","title":"小摩上调Recursion(RXRX.US)评级至“增持”，核心管线REC-4881有望成为畅销药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2592922274","media":"智通财经网","labels":["corporation","rating"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592922274?lang=zh_cn&edition=full","pubTime":"2025-12-18 14:27","pubTimestamp":1766039221,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根大通将Recursion Pharmaceuticals的评级由“中性”上调至“增持”，理由是该公司核心资产REC - 4881具备成为“重磅炸弹”级产品的销售潜力。此外，该行还把Recursion的目标价从10美元提升至11美元。格罗弗写道：“这些临床结果及与制药企业的合作，进一步验证了Recursion的AI驱动研发管线，迄今已带来超过5亿美元的里程碑付款。”截至周三收盘，Recursion收涨11.43%，报4.68美元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,rating","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["RXRX","BK4609","BK4611","BK4548","BK4539","BK4139"],"gpt_icon":1},{"id":"1152493085","title":"Recursion Pharmaceuticals股价上涨6.1%，因其实验性疗法在稀有疾病试验中减少了息肉生长","url":"https://stock-news.laohu8.com/highlight/detail?id=1152493085","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152493085?lang=zh_cn&edition=full","pubTime":"2025-12-08 22:34","pubTimestamp":1765204493,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals股价上涨6.1%，因其实验性疗法在稀有疾病试验中减少了息肉生长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4609","BK4611","BK4548","BK4139","RXRX","BK4539"],"gpt_icon":0},{"id":"1162082872","title":"Recursion：扩大年龄范围至18岁及以上，并进一步优化Rec-4881的给药计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1162082872","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162082872?lang=zh_cn&edition=full","pubTime":"2025-12-08 20:30","pubTimestamp":1765197057,"startTime":"0","endTime":"0","summary":"Recursion：扩大年龄范围至18岁及以上，并进一步优化Rec-4881的给药计划","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4609","BK4539","RXRX","BK4611","BK4139"],"gpt_icon":0},{"id":"1114175506","title":"Recursion：可评估患者中82%在Rec-4881 Tupelo试验第25周维持了减少，基线中位下降53%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114175506","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114175506?lang=zh_cn&edition=full","pubTime":"2025-12-08 20:30","pubTimestamp":1765197048,"startTime":"0","endTime":"0","summary":"Recursion：可评估患者中82%在Rec-4881 Tupelo试验第25周维持了减少，基线中位下降53%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4609","RXRX","BK4548","BK4539","BK4611"],"gpt_icon":0},{"id":"1149287496","title":"Recursion: Rec-4881 Tupelo 1B/2期试验结果显示家族性腺瘤性息肉病的息肉负担在25周内迅速且持久减少","url":"https://stock-news.laohu8.com/highlight/detail?id=1149287496","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149287496?lang=zh_cn&edition=full","pubTime":"2025-12-08 20:30","pubTimestamp":1765197037,"startTime":"0","endTime":"0","summary":"Recursion: Rec-4881 Tupelo 1B/2期试验结果显示家族性腺瘤性息肉病的息肉负担在25周内迅速且持久减少","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4609","RXRX","BK4548","BK4539","BK4611"],"gpt_icon":0},{"id":"1196674557","title":"Recursion Pharmaceuticals, Inc.宣布关于Rec-4881在家族性腺瘤性息肉病的Tupelo 1B/2期临床试验数据发布的网络研讨会","url":"https://stock-news.laohu8.com/highlight/detail?id=1196674557","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196674557?lang=zh_cn&edition=full","pubTime":"2025-12-01 21:32","pubTimestamp":1764595958,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals, Inc.宣布将于2025年12月8日举行网络研讨会，以发布关于Rec-4881在家族性腺瘤性息肉病的Tupelo 1B/2期临床试验的最新数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4548","RXRX","BK4611","BK4609"],"gpt_icon":0},{"id":"1161522573","title":"Recursion Pharmaceuticals 提交最多 710 万股 A 类普通股的公开发行申请 - SEC 文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1161522573","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161522573?lang=zh_cn&edition=full","pubTime":"2025-11-26 21:14","pubTimestamp":1764162856,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals 提交最多 710 万股 A 类普通股的公开发行申请 - SEC 文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4539","BK4139","BK4611","BK4609","BK4548"],"gpt_icon":0},{"id":"1137771451","title":"Recursion Pharmaceuticals第三季度营收498.3万美元，低于IBES预期的1700万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137771451","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137771451?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:40","pubTimestamp":1763570451,"startTime":"0","endTime":"0","summary":"11月5日消息——Recursion Pharmaceuticals第三季度的税前利润为-1.6225亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4609","RXRX","BK4611","BK4139","BK4548","BK4539"],"gpt_icon":0},{"id":"1137595080","title":"英伟达概念股普跌，纳微半导体大跌8%，APLD跌超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137595080","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137595080?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:54","pubTimestamp":1761054890,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals跌超4%。","market":"us","thumbnail":"https://static.tigerbbs.com/f92e0f6db243fa4c651bd54e727021b0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f92e0f6db243fa4c651bd54e727021b0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"15ee133e7201107be6cfd6e50c244292","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVTS","CRWV","RXRX","NBIS","APLD"],"gpt_icon":0},{"id":"2573927472","title":"美股部分AI医疗概念股走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2573927472","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573927472?lang=zh_cn&edition=full","pubTime":"2025-10-08 23:14","pubTimestamp":1759936446,"startTime":"0","endTime":"0","summary":"格隆汇10月8日｜Recursion Pharmaceuticals涨超8%，CRISPR Therapeutics涨近7%，Tempus Al涨超3%，Hims & Hers Health涨超2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008232557a4574674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008232557a4574674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRSP","LU1861559042.SGD","BK4609","BK4588","BK4556","RXRX","BK4196","LU1861558580.USD","BK4611","HIMS","BK4539","BK4139","BK4548","BK4585"],"gpt_icon":0},{"id":"2564386228","title":"美股异动 | 英伟达持仓股普跌 “亲儿子”CoreWeave(CRWV.US)跌超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564386228","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564386228?lang=zh_cn&edition=full","pubTime":"2025-09-02 23:22","pubTimestamp":1756826577,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0d219511f954aa127cc5019686dd7346","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVD2.UK","BK4533","NVDS.UK","LU0889565833.HKD","RXRX","NVDU","ARM","LU0823421416.USD","2NVD.UK","CRWV","LU0170899867.USD","BK4529","LU2108987350.USD","NVDX","LU1674673428.USD","LU2065170008.USD","NVDD","LU0823431647.USD","LU2361044865.SGD","LU0342679015.USD","NVD","LU1852331112.SGD","IE00B19Z9505.USD","LU2361045086.USD","LU1064131342.USD","SG9999014559.SGD","SGXZ51526630.SGD","LU0444971666.USD","LU1035775433.USD","NVDL","LU0950373646.USD","NVDS","NVDY","NVD3.UK","SNVD.UK","LU1923622614.USD","LU2931357623.SGD","NBIS","IE00B19Z8X17.USD","LU2237957811.SGD","NVDA","LU2471134796.USD","3NVD.UK","LU1992135399.USD","LU1868836591.USD","LU2860962120.EUR","IE00BJTD4N35.SGD","NVIW.SI","APLD","LU1934455863.HKD"],"gpt_icon":0},{"id":"2518222608","title":"Recursion Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222608?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:33","pubTimestamp":1741613625,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时33分，Recursion Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.08%。截至发稿，该股报6.26美元/股，成交量116.678万股，换手率0.29%，振幅2.43%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2084.06%、406.02%、63.10%，振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.，振幅分别为100.05%、99.13%、98.72%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213345a26a2579&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213345a26a2579&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4609","BK4611","BK4548","BK4139","RXRX","BK4539"],"gpt_icon":1},{"id":"2516677104","title":"Recursion Pharmaceuticals, Inc.盘中异动 早盘急速跳水5.16%报6.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677104?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098737,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Recursion Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.16%。截至发稿，该股报6.25美元/股，成交量282.348万股，换手率0.70%，振幅1.90%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1048.08%、1033.73%、409.49%，振幅较大的相关个股有Adma Biologics Inc、Ocean Biomedical, Inc.、Aditxt, Inc.，振幅分别为11.75%、10.39%、9.50%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422321796394489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422321796394489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4548","RXRX","BK4539","BK4609"],"gpt_icon":0},{"id":"2516630506","title":"Recursion Pharmaceuticals, Inc.盘中异动 快速跳水5.06%报7.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516630506?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:14","pubTimestamp":1741014893,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时14分，Recursion Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.06%。截至发稿，该股报7.13美元/股，成交量584.537万股，换手率1.45%，振幅9.99%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1588.23%、132.29%、107.64%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为177.97%、70.53%、48.34%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032314549637b807&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032314549637b807&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4609","RXRX","BK4139","BK4548"],"gpt_icon":1},{"id":"2516022813","title":"Leerink Partners：维持Recursion Pharmaceuticals(RXRX.US)评级，由大市一致调整至大市一致评级, 目标价由7.00美元调整至6.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516022813","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516022813?lang=zh_cn&edition=full","pubTime":"2025-03-01 05:47","pubTimestamp":1740779249,"startTime":"0","endTime":"0","summary":"Leerink Partners：维持Recursion Pharmaceuticals(RXRX.US)评级，由大市一致调整至大市一致评级, 目标价由7.00美元调整至6.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":"510abd3fed60ede9221497638d602631","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01054748470353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RXRX"],"gpt_icon":0},{"id":"1108509860","title":"盘前｜英伟达持仓股齐跌，RXRX跌超12%；今晚美联储“首选通胀指标”来袭","url":"https://stock-news.laohu8.com/highlight/detail?id=1108509860","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108509860?lang=zh_cn&edition=full","pubTime":"2025-02-28 20:44","pubTimestamp":1740746647,"startTime":"0","endTime":"0","summary":"报告充斥着诸多不实之词$英伟达$盘前由涨转跌，其持仓概念股纷纷下挫，RXRX跌超12%明星中概股普跌，$小鹏汽车$跌超7%财报股表现：SoundHound AI涨超3%，$戴尔$跌近4%，RKLB跌超15%2月28日，美股三大股指期货上涨，截止发稿，道指期货涨0.37%，纳指期货涨0.06%，标普500指数期货涨0.24%。盘前行情英伟达盘前由涨转跌，其持仓概念股纷纷下挫，Recursion Pharmaceuticals跌超12%，$NEBIUS$跌超4%，Applied Digital跌近4%，$文远知行$跌超2%。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","BK1539","BK4587","IE0004086264.USD","BK1119","IE0004091025.USD","NVDA","IE00BKVL7J92.USD","XPEV","BK4579","RKLB","IE00BJJMRX11.SGD","IE0009356076.USD","BK4555","BK4533","IE00BHPRN162.USD","RXRX","BK4588","GB00BDT5M118.USD"],"gpt_icon":1},{"id":"1127500860","title":"Recursion Pharmaceuticals盘前跌超11%，Q4营收不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1127500860","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127500860?lang=zh_cn&edition=full","pubTime":"2025-02-28 20:09","pubTimestamp":1740744598,"startTime":"0","endTime":"0","summary":"2月28日，Recursion Pharmaceuticals盘前跌超11%，财报显示：2024年第四季度营业收入为451.1万美元，不及市场预期，去年同期1062.4万美元。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c8c8c2b5281507a7192e6f1843c0a37a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Recursion Pharmaceuticals盘前跌超11%，Q4营收不及预期","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RXRX","BK4539","BK4548"],"gpt_icon":0},{"id":"1105563112","title":"异动解读 | RXRX盘前大跌5.87%,业绩低于预期或是主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1105563112","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105563112?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:40","pubTimestamp":1740742851,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals(纳斯达克:RXRX)于周五盘前大跌5.87%,引发了市场广泛关注。\n公司近期公布的2022年第四季度财报显示,每股亏损0.53美元,远超分析师预期的0.46美元亏损。营收方面,RXRX季度销售额仅为455万美元,大幅低于市场预期的1904万美元。\n这一业绩低于预期的情况可能是导致盘前股价大跌的主要原因。不过,目前尚未有其他公开信息可以解释这一跌幅。投资者或需进一步关注公司未来发展,以判断是否存在更深层次的影响因素。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c8c8c2b5281507a7192e6f1843c0a37a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RXRX"],"gpt_icon":0},{"id":"1137020833","title":"Recursion Pharmaceuticals 第四季度每股收益 $(0.53) 不及预期 $(0.46)，销售额 $4.55M 低于预期 $19.04M","url":"https://stock-news.laohu8.com/highlight/detail?id=1137020833","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137020833?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:36","pubTimestamp":1740742604,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals报告季度每股亏损 $，与分析师共识预期的 $ 相比，低了15.22%。与去年同期每股亏损 $ 相比下降了26.19%。以上内容来自Benzinga Earnings专栏，原文如下：Recursion Pharmaceuticals  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 15.22 percent. This is a 26.19 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $4.55 million which missed the analyst consensus estimate of $19.04 million by 76.13 percent.  This is a 58.26 percen","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c8c8c2b5281507a7192e6f1843c0a37a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Recursion Pharmaceuticals 第四季度每股收益 $(0.53) 不及预期 $(0.46)，销售额 $4.55M 低于预期 $19.04M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.recursion.com","stockEarnings":[{"period":"1week","weight":-0.1231},{"period":"1month","weight":-0.2804},{"period":"3month","weight":-0.157},{"period":"6month","weight":-0.3951},{"period":"1year","weight":-0.5894},{"period":"ytd","weight":-0.1467}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0125},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.0595},{"period":"1year","weight":0.1181},{"period":"ytd","weight":-0.0002}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Recursion Pharmaceuticals, Inc.最初成立于2013年11月4日，并在特拉华州注册成立 。 该公司是一家领先的临床阶段TechBio公司，将生物解码以将药物发现产业化。公司使命的核心是递归操作系统（OS），这是一个跨多种技术构建的平台，使公司能够在超过50 PB的专有数据中绘制和导航数万亿个以生物、化学和患者为中心的关系。该公司将物理和数字组件的这种集成框定为迭代循环，其中规模化的“湿实验室”生物学、化学和以患者为中心的实验数据由“干实验室”计算工具组织，以便识别、验证和翻译治疗见解。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.035717},{"month":2,"riseRate":0.4,"avgChangeRate":0.040769},{"month":3,"riseRate":0,"avgChangeRate":-0.270652},{"month":4,"riseRate":0.25,"avgChangeRate":-0.144468},{"month":5,"riseRate":0.4,"avgChangeRate":0.084296},{"month":6,"riseRate":0.6,"avgChangeRate":0.136566},{"month":7,"riseRate":0.8,"avgChangeRate":0.206054},{"month":8,"riseRate":0.2,"avgChangeRate":-0.126569},{"month":9,"riseRate":0.4,"avgChangeRate":-0.050486},{"month":10,"riseRate":0.2,"avgChangeRate":-0.079168},{"month":11,"riseRate":0.4,"avgChangeRate":0.028843},{"month":12,"riseRate":0.2,"avgChangeRate":-0.000986}],"exchange":"NASDAQ","name":"Recursion Pharmaceuticals, Inc.","nameEN":"Recursion Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Recursion Pharmaceuticals, Inc.(RXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Recursion Pharmaceuticals, Inc.,RXRX,Recursion Pharmaceuticals, Inc.股票,Recursion Pharmaceuticals, Inc.股票老虎,Recursion Pharmaceuticals, Inc.股票老虎国际,Recursion Pharmaceuticals, Inc.行情,Recursion Pharmaceuticals, Inc.股票行情,Recursion Pharmaceuticals, Inc.股价,Recursion Pharmaceuticals, Inc.股市,Recursion Pharmaceuticals, Inc.股票价格,Recursion Pharmaceuticals, Inc.股票交易,Recursion Pharmaceuticals, Inc.股票购买,Recursion Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Recursion Pharmaceuticals, Inc.(RXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}